Takimoto Glenn S, Tung Lin, Abdel-Hafiz Hany, Abel Michael G, Sartorius Carol A, Richer Jennifer K, Jacobsen Britta M, Bain David L, Horwitz Kathryn B
Department of Medicine, Molecular Biology Program, University of Colorado Health Sciences Center, Denver, CO 80262, USA.
J Steroid Biochem Mol Biol. 2003 Jun;85(2-5):209-19. doi: 10.1016/s0960-0760(03)00197-3.
Progesterone receptors (PR) are present in two isoforms, PR-A and PR-B. The B-upstream segment (BUS) of PR-B is a 164 amino acid N-terminal extension that is missing in PR-A and is responsible for the functional differences reported between the two isoforms. BUS contains an activation function (AF3) which is defined by a core domain between residues 54-154 whose activity is dependent upon a single Trp residue and two LXXLL motifs. We have also identified sites both within and outside of BUS that repress the strong synergism between AF3 and AF1 in the N-terminal region and AF2 in the hormone binding domain. One of these repressor sites is a consensus binding motif for the small ubiquitin-like modifier protein, SUMO-1 (387IKEE). The DNA binding domain (DBD) structure is also important for function. When BUS is linked to the glucocorticoid receptor DBD, AF3 activity is substantially attenuated, suggesting that binding to a DNA response element results in allosteric communication between the DBD and N-terminal functional regions. Lastly, biochemical and biophysical analyses of highly purified PR-B and PR-A N-terminal regions reveal that they are unstructured unless the DBD is present. Thus, the DBD stabilizes N-terminal structure. We propose a model in which the DBD through DNA binding, and BUS through protein-protein interactions, stabilize active receptor conformers within an ensemble distribution of active and inactive conformational states. This would explain why PR-B are stronger transactivators than PR-A.
孕酮受体(PR)有两种亚型,即PR-A和PR-B。PR-B的B上游片段(BUS)是一个164个氨基酸的N端延伸,PR-A中没有该片段,它负责两种亚型之间报道的功能差异。BUS包含一个激活功能(AF3),该功能由54至154位残基之间的核心结构域定义,其活性取决于单个色氨酸残基和两个LXXLL基序。我们还在BUS内部和外部鉴定出了一些位点,这些位点可抑制N端区域的AF3与激素结合域中的AF2之间的强协同作用。其中一个抑制位点是小泛素样修饰蛋白SUMO-1(387IKEE)的共有结合基序。DNA结合域(DBD)结构对功能也很重要。当BUS与糖皮质激素受体DBD相连时,AF3活性会大幅减弱,这表明与DNA反应元件的结合会导致DBD与N端功能区域之间发生变构通讯。最后,对高度纯化的PR-B和PR-A N端区域的生化和生物物理分析表明,除非存在DBD,它们是无结构的。因此,DBD稳定了N端结构。我们提出了一个模型,其中DBD通过DNA结合,而BUS通过蛋白质-蛋白质相互作用,在活性和非活性构象状态的整体分布中稳定活性受体构象体。这将解释为什么PR-B比PR-A是更强的反式激活因子。